Abstract:With cardiovascular disease (CVD) being a primary source of global morbidity and mortality, it is crucial that we understand the molecular pathophysiological mechanisms at play. Recently, numerous pro-inflammatory cytokines have been linked to several different CVDs, which are now often considered an adversely pro-inflammatory state. These cytokines most notably include interleukin-6 (IL-6),tumor necrosis factor (TNF)α, and the interleukin-1 (IL-1) family, amongst others. Not only does inflammation have intricate and complex interactions with pathophysiological processes such as oxidative stress and calcium mishandling, but it also plays a role in the balance between tissue repair and destruction. In this regard, pre-clinical and clinical evidence has clearly demonstrated the involvement and dynamic nature of pro-inflammatory cytokines in many heart conditions; however, the clinical utility of the findings so far remains unclear. Whether these cytokines can serve as markers or risk predictors of disease states or act as potential therapeutic targets, further extensive research is needed to fully understand the complex network of interactions that these molecules encompass in the context of heart disease. This review will highlight the significant advances in our understanding of the contributions of pro-inflammatory cytokines in CVDs, including ischemic heart disease (atherosclerosis, thrombosis, acute myocardial infarction, and ischemia-reperfusion injury), cardiac remodeling (hypertension, cardiac hypertrophy, cardiac fibrosis, cardiac apoptosis, and heart failure), different cardiomyopathies as well as ventricular arrhythmias and atrial fibrillation. In addition, this article is focused on discussing the shortcomings in both pathological and therapeutic aspects of pro-inflammatory cytokines in CVD that still need to be addressed by future studies.

Roles and Mechanisms of Interleukin-12 Family Members in Cardiovascular Diseases: Opportunities and Challenges

Emerging Role of Interleukin-13 in Cardiovascular Diseases: A Ray of Hope.

The Role of Interleukin-6 Family Members in Cardiovascular Diseases

Advances in interleukin-18 and cardiovascular disease

Role of interleukin‐15 in cardiovascular diseases

Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis.

Roles and mechanism of IL-11 in vascular diseases

Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases

The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease

Interleukin-35 ameliorates cardiovascular disease by suppressing inflammatory responses and regulating immune homeostasis

Role of IL-37 in Cardiovascular Disease Inflammation

Role of IL-12 family in autoimmune diseases

Unveiling the role of IL-17: Therapeutic insights and cardiovascular implications

Role of interleukin-6 in regulation of immune responses to remodeling after myocardial infarction

Insights into the roles of IL-10-producing regulatory B cells in cardiovascular disorders: recent advances and future perspectives

Systematic Review on the Role of IL-6 and IL-1β in Cardiovascular Diseases

Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications

The role of IL-17 family cytokines in cardiac fibrosis

The Role of Interleukin-24 and Downstream Pathways in Inflammatory and Autoimmune Diseases

Role of Treg cell subsets in cardiovascular disease pathogenesis and potential therapeutic targets

The role of interleukin -1 family in fibrotic diseases